SRAGE: a prognostic factor for mortality in end-stage renal disease patients on dialysis

E Dozio, E Vianello, F Ambrogi, M De Cal, C Ronco, L Tacchini, M M Corsi

Article ID: 6442
Vol 32, Issue 4S1, 2018
DOI: https://doi.org/10.54517/jbrha6442
Received: 8 September 2018; Accepted: 8 September 2018; Available online: 8 September 2018; Issue release: 8 September 2018

Abstract

End stage renal disease patients on dialysis (CKD-G5D) have a high mortality rate mainly due to cardiovascular diseases (CVD). In addition to traditional CVD risk factors, which are common in these patients, excessive oxidative stress, uremia and chronic inflammation may further increase the production of advanced glycation end-products (AGEs) which in turn promote CVD and CVD-related morbidity and mortality. Much attention has been paid recently to the soluble receptor for AGEs (sRAGE) as a marker of inflammation, oxidative stress, atherosclerosis and heart failure (HF) in CKD-G5D. However, its relationship with patient outcomes is still debated.



References

Supporting Agencies



Copyright (c) 2018 E Dozio, E Vianello, F Ambrogi, M De Cal, C Ronco, L Tacchini, M M Corsi Romanelli




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).